{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:09:12Z","timestamp":1792001352799,"version":"4.4.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clinre.2023.102185","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T23:14:04Z","timestamp":1690326844000},"page":"102185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Treatment with an ileal bile acid transporter inhibitor in patients with TJP2 deficiency"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0363-5565","authenticated-orcid":false,"given":"Angelo","family":"Di Giorgio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sciveres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Fuoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Sonzogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Mandato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"D'Antiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2023.102185_bib0001","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.4254\/wjh.v13.i12.2024","article-title":"Newer variants of progressive familial intrahepatic cholestasis","volume":"13","author":"Vinayagamoorthy","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.clinre.2023.102185_bib0002","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13052-019-0679-x","article-title":"Cholestatic jaundice in infancy: struggling with many old and new phenotypes","volume":"45","author":"Mandato","year":"2019","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.clinre.2023.102185_bib0003","unstructured":"OMIM, Cholestasis Progressive Familial Intrahepatic, PFIC4. Available from: https:\/\/www.omim.org\/entry\/615878."},{"key":"10.1016\/j.clinre.2023.102185_bib0004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clinre.2018.07.010","article-title":"Systematic review of progressive familial intrahepatic cholestasis","volume":"43","author":"Baker","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2023.102185_bib0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fmed.2020.00149","article-title":"Pediatric cholestatic liver disease: review of bile acid metabolism and discussion of current and emerging therapies","volume":"7","author":"Kriegermeier","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clinre.2023.102185_bib0006","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s40265-021-01594-y","article-title":"Odevixibat: first approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.clinre.2023.102185_bib0007","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","article-title":"Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial","volume":"7","author":"Thompson","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2023.102185_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101751","article-title":"Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: phase 2 study","volume":"45","author":"Baumann","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.clinre.2023.102185_bib0009","volume":"13","author":"\u00d6zen","year":"2022","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.clinre.2023.102185_bib0010","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(21)01256-3","article-title":"Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study","volume":"398","author":"Gonzales","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2023.102185_bib0011","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ng.2918","article-title":"Mutations in TJP2 cause progressive cholestatic liver disease","volume":"46","author":"Sambrotta","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinre.2023.102185_bib0012","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2015.1026537","article-title":"Mutations in TJP2, encoding zona occludens 2, and liver disease","volume":"3","author":"Sambrotta","year":"2015","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.clinre.2023.102185_bib0013","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s13023-022-02427-1","article-title":"Clinical and genetic spectrum of primary ciliary dyskinesia in Chinese patients: a systematic review","volume":"17","author":"Peng","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clinre.2023.102185_bib0014","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/humu.23947","article-title":"TJP2 hepatobiliary disorders: novel variants and clinical diversity","volume":"41","author":"Zhang","year":"2020","journal-title":"Hum Mutat"},{"issue":"9","key":"10.1016\/j.clinre.2023.102185_bib0015","article-title":"Two novel pathogenic variants of TJP2 gene and the underlying molecular mechanisms in progressive familial intrahepatic cholestasis type 4 patients","volume":"24","author":"Tang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.clinre.2023.102185_bib0016","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740123001109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740123001109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:34:13Z","timestamp":1761896053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740123001109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2210740123001109"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2023.102185","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with an ileal bile acid transporter inhibitor in patients with TJP2 deficiency","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2023.102185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102185"}}